Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Genetic polymorphisms in NQO1 and SOD2: interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt.

Goerlitz D, Amr S, Dash C, Saleh DA, El Daly M, Abdel-Hamid M, El Kafrawy S, Hifnawy T, Ezzat S, Abdel-Aziz MA, Khaled H, Zheng YL, Mikhail N, Loffredo CA.

Urol Oncol. 2014 Jan;32(1):47.e15-20. doi: 10.1016/j.urolonc.2013.06.016. Epub 2013 Sep 10.

2.

Pesticides, gene polymorphisms, and bladder cancer among Egyptian agricultural workers.

Amr S, Dawson R, Saleh DA, Magder LS, St George DM, El-Daly M, Squibb K, Mikhail NN, Abdel-Hamid M, Khaled H, Loffredo CA.

Arch Environ Occup Health. 2015;70(1):19-26. doi: 10.1080/19338244.2013.853646.

3.

CYP2E1 and NQO1 genotypes, smoking and bladder cancer.

Choi JY, Lee KM, Cho SH, Kim SW, Choi HY, Lee SY, Im HJ, Yoon KJ, Choi H, Choi I, Hirvonen A, Hayes RB, Kang D.

Pharmacogenetics. 2003 Jun;13(6):349-55.

PMID:
12777965
4.

Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk.

Hung RJ, Boffetta P, Brennan P, Malaveille C, Gelatti U, Placidi D, Carta A, Hautefeuille A, Porru S.

Carcinogenesis. 2004 Jun;25(6):973-8. Epub 2004 Jan 16.

PMID:
14729580
5.

An association between NQO1 genetic polymorphism and risk of bladder cancer.

Park SJ, Zhao H, Spitz MR, Grossman HB, Wu X.

Mutat Res. 2003 Apr 20;536(1-2):131-7.

PMID:
12694753
6.

Human NAD(P)H:quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan.

Wang YH, Lee YH, Tseng PT, Shen CH, Chiou HY.

J Cancer Res Clin Oncol. 2008 Feb;134(2):203-9. Epub 2007 Jul 10.

PMID:
17619904
7.

GSTM1, GSTT1 null variants, and GPX1 single nucleotide polymorphism are not associated with bladder cancer risk in Egypt.

Goerlitz D, El Daly M, Abdel-Hamid M, Saleh DA, Goldman L, El Kafrawy S, Hifnawy T, Ezzat S, Abdel-Aziz MA, Zaghloul MS, Ali SR, Khaled H, Amr S, Zheng YL, Mikhail N, Loffredo C.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1552-4. doi: 10.1158/1055-9965.EPI-10-1306. Epub 2011 May 17.

8.

Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.

Zhang H, Wen X, Lu X, Zhang H.

Tumour Biol. 2013 Dec;34(6):3377-81. doi: 10.1007/s13277-013-0909-6. Epub 2013 Jul 20.

PMID:
23873104
9.

Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.

Gong M, Yi Q, Wang W.

Tumour Biol. 2013 Oct;34(5):2551-6. doi: 10.1007/s13277-013-0799-7. Epub 2013 Jun 8. Review.

PMID:
23749485
10.

Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.

Pandith AA, Khan NP, Shah ZA, Shah AM, Wani SM, Siddiqi MA.

Biochem Genet. 2011 Aug;49(7-8):417-26. doi: 10.1007/s10528-011-9418-8. Epub 2011 Jan 21.

PMID:
21253823
11.

Association of polymorphisms in iNOS and NQO1 with bladder cancer risk in cigarette smokers.

Huang ZM, Chen HA, Chiang YT, Shen CH, Tung MC, Juang GD.

J Chin Med Assoc. 2014 Feb;77(2):83-8. doi: 10.1016/j.jcma.2013.10.005. Epub 2013 Dec 5.

12.

Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer.

Olson SH, Carlson MD, Ostrer H, Harlap S, Stone A, Winters M, Ambrosone CB.

Gynecol Oncol. 2004 Jun;93(3):615-20.

PMID:
15196853
13.

NQO1 609C>T polymorphism interaction with tobacco smoking and alcohol drinking increases colorectal cancer risk in a Chinese population.

Peng XE, Jiang YY, Shi XS, Hu ZJ.

Gene. 2013 May 25;521(1):105-10. doi: 10.1016/j.gene.2013.02.029. Epub 2013 Feb 28.

PMID:
23458878
14.

No association between SOD2 or NQO1 genotypes and risk of bladder cancer.

Terry PD, Umbach DM, Taylor JA.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):753-4. No abstract available.

15.

Genetic variants of NQO1 gene increase bladder cancer risk in Indian population and meta-analysis.

Mandal RK, Dubey S, Panda AK, Mittal RD.

Tumour Biol. 2014 Jul;35(7):6415-23. doi: 10.1007/s13277-014-1869-1. Epub 2014 Mar 28.

PMID:
24676794
16.

Polymorphisms of NRF2 and NRF2 target genes in urinary bladder cancer patients.

Reszka E, Jablonowski Z, Wieczorek E, Jablonska E, Krol MB, Gromadzinska J, Grzegorczyk A, Sosnowski M, Wasowicz W.

J Cancer Res Clin Oncol. 2014 Oct;140(10):1723-31. doi: 10.1007/s00432-014-1733-0. Epub 2014 Jun 12.

17.

NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.

Chao C, Zhang ZF, Berthiller J, Boffetta P, Hashibe M.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):979-87.

18.

Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.

Nisa H, Kono S, Yin G, Toyomura K, Nagano J, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Maekawa T, Yasunami Y, Takenaka K, Ichimiya H, Terasaka R.

BMC Cancer. 2010 Jun 10;10:274. doi: 10.1186/1471-2407-10-274.

19.

Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina.

Moore LE, Wiencke JK, Bates MN, Zheng S, Rey OA, Smith AH.

Cancer Lett. 2004 Aug 10;211(2):199-207.

PMID:
15219943
20.

CYP1A1, GSTM1, GSTT1 and NQO1 polymorphisms and colorectal adenomas in Japanese men.

Hamachi T, Tajima O, Uezono K, Tabata S, Abe H, Ohnaka K, Kono S.

World J Gastroenterol. 2013 Jul 7;19(25):4023-30. doi: 10.3748/wjg.v19.i25.4023.

Supplemental Content

Support Center